Your browser doesn't support javascript.
loading
Cost-utility analysis of interferon-free treatments for patients with early-stage genotype 1 hepatitis C virus in Brazil
Ferreira, Vinicius Lins; Leonart, Leticia Paula; Pedroso, Maria Lucia Alves; Pontarolo, Roberto.
  • Ferreira, Vinicius Lins; Universidade Federal do Paraná. Programa de Pós-Graduação em Ciências Farmacêuticas. Curitiba. BR
  • Leonart, Leticia Paula; Universidade Federal do Paraná. Programa de Pós-Graduação em Ciências Farmacêuticas. Curitiba. BR
  • Pedroso, Maria Lucia Alves; Universidade Federal do Paraná. Hospital de Clínicas. Serviço de Gastroenterologia. Curitiba. BR
  • Pontarolo, Roberto; Universidade Federal do Paraná. Programa de Pós-Graduação em Ciências Farmacêuticas. Curitiba. BR
Rev. Soc. Bras. Med. Trop ; 53: e20190594, 2020. tab, graf
Article Dans Anglais | SES-SP, ColecionaSUS, LILACS | ID: biblio-1136866
ABSTRACT
Abstract INTRODUCTION We conducted a cost-utility analysis of available interferon-free treatments for patients with early-stage genotype 1 chronic hepatitis C based on a Brazilian public health system perspective. METHODS A Markov model was derived using a cohort of stage F0-F2 patients treated as recommended by the Brazilian national guidelines.

RESULTS:

Glecaprevir plus pibrentasvir was superior to all other treatments, followed by sofosbuvir plus velpatasvir. Sofosbuvir plus daclatasvir was identified as the least cost-effective option.

CONCLUSIONS:

The above findings were confirmed via probabilistic sensitivity analysis and the tested scenarios.
Sujets)


Texte intégral: Disponible Indice: LILAS (Amériques) Sujet Principal: Antiviraux / Hepacivirus / Hépatite C chronique / Association de médicaments Type d'étude: Guide de pratique / Évaluation en économique de la santé / Étude pronostique Limites du sujet: Humains Pays comme sujet: Amérique du Sud / Brésil langue: Anglais Texte intégral: Rev. Soc. Bras. Med. Trop Année: 2020 Type: Article Institution/Pays d'affiliation: Universidade Federal do Paraná/BR

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS


Texte intégral: Disponible Indice: LILAS (Amériques) Sujet Principal: Antiviraux / Hepacivirus / Hépatite C chronique / Association de médicaments Type d'étude: Guide de pratique / Évaluation en économique de la santé / Étude pronostique Limites du sujet: Humains Pays comme sujet: Amérique du Sud / Brésil langue: Anglais Texte intégral: Rev. Soc. Bras. Med. Trop Année: 2020 Type: Article Institution/Pays d'affiliation: Universidade Federal do Paraná/BR